Role of Nanomedicine in the Diagnosis of Cardiovascular Diseases
- Authors: Foziyah Zakir1, Mohd. Aamir Mirza2, Rahmuddin Khan3, Zeenat Iqbal4
-
View Affiliations Hide Affiliations1 Nanomedicine Laboratory, Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi 110062, India 2 Nanomedicine Laboratory, Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi-110062, India 3 Nanomedicine Laboratory, Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi-110062, India 4 Nanomedicine Laboratory, Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi-110062, India
- Source: Nanomedicinal Approaches Towards Cardiovascular Disease , pp 17-29
- Publication Date: July 2021
- Language: English
Role of Nanomedicine in the Diagnosis of Cardiovascular Diseases, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789814998215/chapter-3-1.gif
Various lifestyle related factors are primarily responsible for the increase of cardiovascular diseases. The development of numerous diseases such as acute myocardial infarction, stroke and thrombosis need multiple therapies. These therapies are based on synthetic active ingredients, which in long-term usage, give adverse side effects. Currently, a lot of attention has been focused on nanotechnology based drug formulation, which can provide sustained drug release, increased half-life, and in turn, can circumvent limitations of conventional therapies. With the advent of the nanomedical approach, the survival length of the patients can be prolonged. This chapter mostly focuses on widely used nanomedicines in therapy and imaging of cardiovascular diseases.
-
From This Site
/content/books/9789814998215.chapter-3dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
